BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6715524)

  • 1. Disk diffusion susceptibility testing of ticarcillin plus clavulanic acid.
    Fuchs PC; Jones RN; Barry AL; Thornsberry C
    J Clin Microbiol; 1984 Apr; 19(4):555-7. PubMed ID: 6715524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrepancies between disk diffusion and broth susceptibility studies of the activity of ticarcillin plus clavulanic acid against ticarcillin-resistant Pseudomonas aeruginosa.
    Manian FA; Alford RH
    Antimicrob Agents Chemother; 1986 Jul; 30(1):35-8. PubMed ID: 3092732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reassessment of susceptibility test interpretive criteria for ticarcillin and ticarcillin-clavulanic acid.
    Fuchs PC; Jones RN; Barry AL
    J Clin Microbiol; 1989 Nov; 27(11):2475-81. PubMed ID: 2808671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates.
    Fuchs PC; Barry AL; Thornsberry C; Jones RN
    Antimicrob Agents Chemother; 1984 Mar; 25(3):392-4. PubMed ID: 6721472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative disk and broth dilution susceptibility test results with ticarcillin and timentin against Pseudomonas aeruginosa and Pseudomonas maltophilia.
    Traub WH; Spohr M
    Chemotherapy; 1987; 33(5):340-6. PubMed ID: 3117502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of clavulanic acid on the susceptibility of clinical anaerobic bacteria to ticarcillin: a multicenter study.
    Fuchs PC; Jones RN; Barry AL; Allen SD; Aldridge KE; Gerlach EH; Sommers HM
    Diagn Microbiol Infect Dis; 1988 Jan; 9(1):47-50. PubMed ID: 3370931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro activity of the combination ticarcillin-clavulanic acid on bacterial isolates in surgery].
    Branger C; Kitzis M; Le Mée J
    Pathol Biol (Paris); 1986 Apr; 34(4):245-8. PubMed ID: 3528998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of gram-negative bacteria and Staphylococcus aureus to combinations of ticarcillin and clavulanic acid.
    Casey P; Glauser M
    Eur J Clin Microbiol; 1983 Dec; 2(6):541-7. PubMed ID: 6607834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vitro susceptibilities of 504 bacteremic isolates to ticarcillin plus clavulanic acid and other antimicrobial agents.
    Rotstein C; Amsterdam D; Beam T; Gorzynski E
    Diagn Microbiol Infect Dis; 1989; 12(2):157-63. PubMed ID: 2752713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of ticarcillin plus clavulanic acid against bacteria isolated in three centers.
    Barry AL; Ayers LW; Gavan TL; Gerlach EH; Jones RN
    Eur J Clin Microbiol; 1984 Jun; 3(3):203-6. PubMed ID: 6147246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of clavulanic acid on the activity of ticarcillin against Pseudomonas aeruginosa.
    Tausk F; Stratton CW
    Antimicrob Agents Chemother; 1986 Oct; 30(4):584-9. PubMed ID: 3098162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial activity of ticarcillin in the presence of clavulanate potassium.
    Sutherland R; Beale AS; Boon RJ; Griffin KE; Slocombe B; Stokes DH; White AR
    Am J Med; 1985 Nov; 79(5B):13-24. PubMed ID: 3878080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of ticarcillin plus clavulanic acid (BRL 28500, 'Timentin') against ticarcillin-resistant gram-negative rods.
    Chattopadhyay B; Hall I
    Curr Med Res Opin; 1984; 9(3):157-60. PubMed ID: 6568146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of clavulanic acid, amoxicillin, and ticarcillin against Chlamydia trachomatis.
    Bowie WR
    Antimicrob Agents Chemother; 1986 Apr; 29(4):713-5. PubMed ID: 3707116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 beta-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests.
    Sanders CC; Iaconis JP; Bodey GP; Samonis G
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1365-9. PubMed ID: 3143303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility testing recommendations for ticarcillin/clavulanic acid in the Stokes' disc diffusion test.
    Sutherland R
    J Antimicrob Chemother; 1989 Sep; 24(3):463-4. PubMed ID: 2808198
    [No Abstract]   [Full Text] [Related]  

  • 17. Bactericidal effects of ticarcillin-clavulanic acid against beta-lactamase-producing bacteria in vivo.
    Boon RJ; Beale AS; Sutherland R
    Antimicrob Agents Chemother; 1986 May; 29(5):838-44. PubMed ID: 3524431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of ticarcillin-resistant gram-negative bacilli to different combinations of ticarcillin and clavulanic acid.
    Verbist L; Verhaegen J
    J Antimicrob Chemother; 1986 May; 17 Suppl C():7-15. PubMed ID: 3636338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ticarcillin and ticarcillin-clavulanic acid susceptibility tests: error rates for disk tests with consecutively isolated members of the family Enterobacteriaceae.
    Barry AL; Fuchs PC; Gerlach EH; Hardy DJ; McLaughlin JC; Pfaller MA
    Antimicrob Agents Chemother; 1992 Jan; 36(1):137-43. PubMed ID: 1590679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation effect of clavulanic acid with penicillin, cephalothin and ticarcillin against Bacteroides fragilis.
    Bansal MB; Chuah SK; Oryema-Lalobo M; Thadepalli H
    Chemotherapy; 1985; 31(3):173-7. PubMed ID: 3996086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.